Partner Headlines - ARNA

  1. Zafgen Plunges On Death In Obesity-Drug Trial

    IBD
  2. Eisai Announces FDA Accepts NDA for Once-Daily Formulation of ...

    Benzinga
  3. Benzinga's Top #PreMarket Gainers

    Benzinga
  4. Keep an Eye on These 5 Stocks for November 11, 2015

    Benzinga
  5. Amira Nature Foods, AlarmCom, Flotek Moving In Tuesday's After ...

    Benzinga
  6. Earnings Scheduled For November 10, 2015

    Benzinga
  7. Monday's After-Hours Movers Led By Du Pont, Arena Pharma, Illumina ...

    Benzinga
  8. Fast Money Traders Share Their Under $5 Stock Picks

    Benzinga
  9. Wednesday's Mid-Day Movers: Does The U.S. Benefit From Iran Deal?; ...

    Benzinga
  10. Wednesday's Mid-Day Movers: Does The U.S. Benefit From Iran Deal?; ...

    Benzinga
  11. Celgene Hits High As Street Applauds Receptos Buyout

    IBD
  12. Mid-Morning Market Update: Markets Mostly Higher; Bank Of America ...

    Benzinga
  13. Sportsman's Warehouse, Bob Evans, Peabody Energy Lead Tuesday's ...

    Benzinga
  14. 5 New Biotech Developments Worth Watching

    Benzinga
  15. Morning Market Gainers

    Benzinga
  16. Benzinga's Top #PreMarket Gainers

    Benzinga
  17. Pharmacological Advancements in Neuroscience Drug Discovery & ...

    Benzinga
  18. Orexigen Soars On Obesity Drug's Surprise Health Boon

    IBD
  19. Morning Market Losers

    Benzinga
  20. Benzinga's Top #PreMarket Losers

    Benzinga
  21. 10 Stocks You Should Be Watching Today

    Benzinga
  22. Arena Pharmaceuticals Misses Q4 Expectations

    Benzinga
  23. Earnings Scheduled For March 2, 2015

    Benzinga
  24. CNBC's Stock Pops & Drops From January 21

    Benzinga
  25. Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following ...

    Benzinga
  26. 4 More Biotech Secondaries Traders Are Watching

    Benzinga
  27. Mid-Day Market Update: U.S. Stocks Surge; Netflix Shares Jump ...

    Benzinga
  28. Mid-Morning Market Update: Markets Mixed; UnitedHealth Profit ...

    Benzinga
  29. Morning Market Losers

    Benzinga
  30. Wednesday Morning Movers: Netflix Flying High

    Benzinga
  31. Arena Pharmaceuticals Announces Agreement to Sell Common Stock

    Benzinga
  32. Benzinga's Top #PreMarket Losers

    Benzinga
  33. Tuesday's After-Hours Movers: Netflix Leads The Pack

    Benzinga
  34. 5 Obesity Stocks Investors Are Watching

    Benzinga
  35. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  36. Mid-Afternoon Market Update: Dow Jumps Over 200 Points After ...

    Benzinga
  37. Mid-Day Market Update: J C Penney Jumps On Strong Holiday Sales; ...

    Benzinga
  38. Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops ...

    Benzinga
  39. Morning Market Gainers

    Benzinga
  40. Benzinga's Top #PreMarket Gainers

    Benzinga
  41. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD
  42. Orexigen Therapeutics Gains On Diet Pill Nod From European Committee

    Benzinga
  43. Pharmaceutical Stocks In Play Following Merck/Cubist Deal

    Benzinga
  44. What's Driving Orexigen Therapeutics Higher?

    Benzinga
  45. Benzinga's Top #PreMarket Gainers

    Benzinga
  46. Arena Pharma Reports Q3 EPS Loss $0.05, Revenues Of $8.16M Vs. ...

    Benzinga
  47. Earnings Scheduled For November 3, 2014

    Benzinga
  48. 3 Pharma Companies Fighting Obesity

    Benzinga
  49. Benzinga's Top #PreMarket Gainers

    Benzinga
  50. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga
  51. Eisai And Arena Pharmaceuticals Announce Publication Of Pooled ...

    Benzinga
  52. Earnings Scheduled For August 1, 2014

    Benzinga
  53. Benzinga's Top #PreMarket Losers

    Benzinga
  54. Markets Marginally Lower Ahead Of Earnings Season

    Benzinga
  55. Arena Pharmaceutical Shares Dive On News CEO Sold 40% Of His ...

    Benzinga
  56. Benzinga's Top #PreMarket Losers

    Benzinga
  57. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga
  58. FDA delays Orexigen drug

    IBD
  59. Is Arena Pharmaceuticals A Biotech Stock To Watch?

    Benzinga
  60. Orexigen Obesity Drug Decision Delayed By FDA

    IBD
  61. Orexigen Shares Plummet Following FDA Decision; Competition Gets ...

    Benzinga
  62. Arena Pharma Posts Q1 Loss Of $0.12/Share, Misses By ~$0.02/Share

    Benzinga
  63. Earnings Scheduled For May 12, 2014

    Benzinga
  64. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE ...

    Benzinga
  65. Benzinga's Top #PreMarket Losers

    Benzinga
  66. Earnings Scheduled For February 27, 2014

    Benzinga
  67. Bad Earnings Weigh In On Diet Stocks

    Benzinga
  68. Top Trending Tickers On StockTwits For February 14

    Benzinga
  69. #PreMarket Primer: Friday, February 14: A Turnaround

    Benzinga
  70. Arena Pharmaceuticals Announces Filing for Marketing Authorization ...

    Benzinga
  71. Celgene To Release Earnings At J.P. Morgan Event Mon.

    IBD
  72. The Top Five Drug Launches Of 2013

    IBD
  73. (ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance ...

    GuruFocus
  74. Benzinga's Top #PreMarket Gainers

    Benzinga
  75. Market Wrap For November 11: Relative Quiet as Traders and Investors ...

    Benzinga
  76. Market Wrap For November 8: Markets Erase Thursday's Losses; ...

    Benzinga
  77. Arena Pharmaceuticals, Eisai Expand Marketing and Supply Agreement ...

    Benzinga
  78. Nasdaq Leads Stocks Lower; Twitter IPO Opens To 80% Gain

    IBD
  79. How Arena’s “$3 Billion” Belviq Withered

    YCharts
  80. Benzinga's Top #PreMarket Losers

    Benzinga
  81. Market Wrap For Tuesday, October 15: Earnings Reports And White ...

    Benzinga
  82. Mid-Afternoon Market Update: Tumi Holdings Rises Amid Market ...

    Benzinga
  83. Mid-Morning Market Update: Markets Slip; Citigroup Profit Misses ...

    Benzinga
  84. UPDATE: Arena Says Eisai Will Double BELVIQ Sales Force to 4 ...

    Benzinga
  85. Vivus Weighs In As a Leader for Diet Pills, Cowen Upgrades and ...

    Benzinga
  86. Obesity Drug Stocks Jump As Cowen Gets Bullish

    IBD
  87. Benzinga's Top Pre-Market Losers

    Benzinga
  88. Market Wrap For September 30: Debt Ceiling And Government Shutdown ...

    Benzinga
  89. Mid-Afternoon Market Update: Mellanox Rallies As Market Remains ...

    Benzinga
  90. Mid-Day Market Update: Dow Falls Over 100 Points; Active Network ...

    Benzinga
  91. Mid-Morning Market Update: Markets Open Lower; Cal-Maine Q1 Net ...

    Benzinga
  92. UPDATE: Credit Suisse Lowers PT on Arena Pharmaceuticals Following ...

    Benzinga
  93. Arena Pharma Offers Update on Eisai Launch of BELVIQ, Says Placing ...

    Benzinga
  94. Stocks Hitting 52-Week Lows

    Benzinga
  95. BMO Considers Recent Sales Data on Arena's Belviq, Maintains ...

    Benzinga
  96. CEO Shift Aside, Whose Weight-Loss Pill’s Ahead

    YCharts
  97. Stocks Hitting 52-Week Lows

    Benzinga
  98. Stocks Hitting 52-Week Lows

    Benzinga
  99. Arena Pharma Reports Closing of Phase 1b Clinical Trial for APD811

    Benzinga
  100. Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, ...

    Benzinga
Trading Center